Prof. Dr. Christian Pilarsky


Professur für Chirurgische Forschung
Chirurgische Klinik

Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 2 Go to next page Go to last page

Patzak, M.S., Kari, V., Patil, S., Hamdan, F.H., Goetze, R.G., Brunner, M.,... Neesse, A. (2019). Cytosolic 5 '-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolites. EBioMedicine, 40, 394-405.
Casadonte, R., Kriegsmann, M., Perren, A., Baretton, G., Deininger, S.-O., Kriegsmann, K.,... Kriegsmann, J. (2019). Development of a Class Prediction Model to Discriminate Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor by MALDI Mass Spectrometry Imaging. Proteomics Clinical Applications, 13(1).
Kalb, M., Langheinrich, M.C., Merkel, S., Krautz, C., Brunner, M., Bénard, A.,... Weber, G. (2019). Influence of body mass index on long-term outcome in patients with rectal cancer-a single centre experience. Cancers, 11(5).
Liu, B., & Pilarsky, C. (2018). Analysis of DNA Hypermethylation in Pancreatic Cancer Using Methylation-Specific PCR and Bisulfite Sequencing. Methods in molecular biology (Clifton, N.J.), 1856, 269-282.
Britzen-Laurent, N., Straube, J., Waldner, M., Becker, C., Croner, R., Pilarsky, C.,... Stürzl, M. (2018). Loss of IFN-gamma pathway gene expression in tumor cells as mechanism of immune escape of colorectal carcinoma. In CANCER RESEARCH. Chicago, IL, US: PHILADELPHIA: AMER ASSOC CANCER RESEARCH.
Christodoulou, E.G., Yang, H., Lademann, F., Pilarsky, C., Beyer, A., & Schroeder, M. (2017). Detection of COPB2 as a KRAS synthetic lethal partner through integration of functional genomics screens. Oncotarget, 8(21), 34283-34297.
Humphris, J.L., Patch, A.-M., Nones, K., Bailey, P.J., Johns, A.L., Mckay, S.,... Pilarsky, C. (2017). Hypermutation In Pancreatic Cancer. Gastroenterology, 152(1), 68-74.e2.
Mayerle, J., Kalthoff, H., Reszka, R., Kamlage, B., Peter, E., Schniewind, B.,... Lerch, M.M. (2017). Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis. Gut.
Krebs, A.M., Mitschke, J., Losada, M.L., Schmalhofer, O., Boerries, M., Busch, H.,... Pilarsky, C. (2017). The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nature Cell Biology, 19(5), 518-529.
Jahny, E., Yang, H., Liu, B., Jahnke, B., Lademann, F., Knoesel, T.,... Pilarsky, C. (2017). The G Protein-Coupled Receptor RAI3 Is an Independent Prognostic Factor for Pancreatic Cancer Survival and Regulates Proliferation via STAT3 Phosphorylation. PLoS ONE, 12(1), e0170390.

Zuletzt aktualisiert 2017-13-07 um 05:42